Sawhney Roger bought ACTU
May 21, 2026 · Form 4 insider transaction
Sawhney Roger bought 15,000 shares of Actuate Therapeutics, Inc. Common stock at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$0.00
Total value
N/A
InsiderSawhney Roger
Role—
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateMay 21, 2026
Filing dateMay 22, 2026
Shares owned after15,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Options will vest in full on the anniversary of the grant date.